Efficacy and Safety Study of Caldolor (Intravenous Ibuprofen) in Hospitalized Adult and Pediatric Burn Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Burns
Interventions
DRUG

Caldolor

800 milligrams of intravenous ibuprofen (patients greater 12 years of age) or 10 milligrams/kilograms (patients greater than 12 years; maximum of 400 milligrams) every 6 hours

DRUG

Placebo

Placebo

Trial Locations (5)

27157

Wake Forest University Health Sciences, Winston-Salem

390001

Naik's Hospital, Baroda

400022

Lokmanya Tilak Municipal Medical College, Mumbai

Unknown

Orlando Regional Medical Center, Orlando

411 011

Surya Hospitals Pvt. Ltd, Pune

Sponsors
All Listed Sponsors
lead

Cumberland Pharmaceuticals

INDUSTRY

NCT00606489 - Efficacy and Safety Study of Caldolor (Intravenous Ibuprofen) in Hospitalized Adult and Pediatric Burn Patients | Biotech Hunter | Biotech Hunter